Physician profile
Judson G Black
NPI 1558468728
$502.18
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $481 · 2021: $21.17.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $128.64 | 2019 | |
| Pfizer INC. | $78.95 | 2019 | |
| Amarin Pharma, INC. | $47.27 | 2019 | |
| Vivus LLC | $37.72 | 2019 | |
| Insulet Corporation | $36.17 | 2019 | |
| Abbvie INC. | $32.69 | 2019-2021 | |
| Ferring Pharmaceuticals INC. | $19.56 | 2019 | |
| Sanofi-Aventis U.S. LLC | $18.70 | 2019 | |
| Novo Nordisk INC | $18.60 | 2019 | |
| Abbott Laboratories | $15.95 | 2019 | |
| Mannkind Corporation | $15.45 | 2019 | |
| Aytu Biopharma, INC. | $14.27 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $14.13 | 2019 | |
| Merck Sharp & Dohme LLC | $12.45 | 2019 | |
| Ibsa Pharma INC. | $11.63 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Judson Black listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.